ClinicalTrials.Veeva

Menu

Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery

B

Branch Office of "Hadassah Medical Ltd"

Status

Enrolling

Conditions

Breast Cancer Stage II
In Situ Breast Cancer
Breast Cancer Stage I

Treatments

Procedure: Implant-based breast reconstruction using polytetrafluoroethylene mesh
Procedure: Implant-based breast reconstruction using Allogeneic dura mater graft

Study type

Interventional

Funder types

Other

Identifiers

NCT06931548
BREAST-ONE

Details and patient eligibility

About

There is currently no consensus on the "gold standard" for Implant-based Breast reconstruction. In the United States, more than half of all breast reconstructions are performed using acellular dermal matrix (ADM). However, based on the findings of literature and systematic reviews, it can be cautiously said that synthetic meshes cause fewer complications with comparable aesthetic results and low cost. In our study, we propose using polytetrafluoroethylene (PTFE) mesh in implant-based breast reconstruction. This material has previously proven itself in cardiovascular, maxillofacial and neurosurgery, hernioplasty and as a suture material. Allogeneic dura mater, which has demonstrated comparable results in breast reconstruction with the literature, will be used as a comparison. The purpose of this study is to evaluate the efficacy and safety of a porous, non-biodegradable, synthetic polytetrafluoroethylene mesh for implant-based breast reconstruction in patients diagnosed with breast cancer. An allogeneic dura mater technique will be used as a control.

Patients eligible for this study are classified according to the National Comprehensive Cancer Network (NCCN) guidelines as having stage 0-2 breast cancer.

The primary questions this study aims to answer are:

  • What are the rates of major and minor complications associated with these techniques. Major complications will be defined as complications leading to reoperation.
  • How effective are PTFE mesh and dura in maintaining the inframammary fold and implant projection after breast reconstruction?
  • What is the patient satisfaction rate with the surgical results?

Patients will be randomly assigned to the study but will know which technique will be used in their particular case. Patients included in this study will undergo subcutaneous mastectomy or skin-sparing mastectomy using standard techniques with simultaneous implantation using PTFE mesh or allogeneic dura mater graft. In our opinion, the mesh and graft will stabilize the projections of the inframammary fold and breast implant.

After the surgery, all minor and major complications will be recorded for 6 months. For this, both physical examination and radiological diagnostic methods will be used, including breast ultrasound and MRI with contrast. Revision surgeries will be performed if necessary.

Projections of the inframammary fold and breast implant will also be measured in order to determine the effectiveness of the compared techniques.

Patients will be asked to complete the BREAST-Q Version 2.0© Reconstruction Module questionnaire to determine satisfaction with the surgical outcome.

The results of the study will help the professional community to determine the most effective method of Implant-based Breast reconstruction and will be published in peer-reviewed scientific journals.

Enrollment

100 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • White women;
  • Breast cancer stage 0-II;
  • Indications for breast reconstruction;
  • Consent to participate in the study and photographic documentation.

Exclusion criteria

  • Non-white women;
  • Breast cancer stage III-IV;
  • Tubular breast;
  • Mental and cognitive health disorders;
  • Failure to comply with recommendations in the postoperative period (premature physical activity, not wearing compression underwear, missing scheduled visits, refusal of photo documentation);
  • Patient refusal to participate in the study at any stage.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Polytetrafluoroethylene mesh
Experimental group
Description:
Patients in this group will undergo one-stage breast reconstruction using an implant and polytetrafluoroethylene (PTFE) mesh after subcutaneous or skin-sparing mastectomy.
Treatment:
Procedure: Implant-based breast reconstruction using polytetrafluoroethylene mesh
Allogeneic dura mater graft
Active Comparator group
Description:
Patients in this group will undergo one-stage breast reconstruction using an implant and allogeneic dura mater graft after subcutaneous or skin-sparing mastectomy.
Treatment:
Procedure: Implant-based breast reconstruction using Allogeneic dura mater graft

Trial contacts and locations

1

Loading...

Central trial contact

Artem Mishin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems